Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transient ischaemic attacks. Current treatment concepts.

C Warlow

    Drugs
    |May 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Transient ischaemic attacks (TIAs) are common and carry a significant risk of stroke. Managing vascular risk factors like hypertension is crucial, with aspirin showing promise for long-term use.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nitrous oxide exposure does not seem to be associated with increased mortality, stroke, and myocardial infarction: a non-randomized subgroup analysis of the General Anaesthesia compared with Local Anaesthesia for carotid surgery (GALA) trial.

    British journal of anaesthesia·2012
    Same author

    Which neurological diseases are most likely to be associated with "symptoms unexplained by organic disease".

    Journal of neurology·2011
    Same author

    Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'.

    Journal of neurology, neurosurgery, and psychiatry·2011
    Same author

    Who is referred to neurology clinics?--the diagnoses made in 3781 new patients.

    Clinical neurology and neurosurgery·2010
    Same author

    Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?

    Brain : a journal of neurology·2009
    Same author

    Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome.

    Psychological medicine·2009
    Same journal

    Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

    Drugs·2026
    Same journal

    Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

    Drugs·2026
    Same journal

    Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

    Drugs·2026
    Same journal

    Relacorilant: First Approval.

    Drugs·2026
    Same journal

    Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

    Drugs·2026
    Same journal

    Linerixibat: First Approval.

    Drugs·2026
    See all related articles

    Area of Science:

    • Neurology
    • Cardiovascular Medicine
    • Public Health

    Background:

    • Transient ischaemic attacks (TIAs) are prevalent, affecting at least 50 per 100,000 individuals annually.
    • TIAs present a substantial annual risk of stroke and/or death, estimated at 10%.
    • Mortality is frequently linked to coronary artery disease complications rather than cerebrovascular disease.

    Purpose of the Study:

    • To highlight the critical importance of differentiating TIAs from other transient focal neurological attacks.
    • To emphasize the necessity of managing general vascular disease risk factors, especially hypertension.
    • To review the current understanding and ongoing research into antithrombotic treatments for TIAs.

    Main Methods:

    • Review of existing literature and clinical trial data on TIA management.

    Related Experiment Videos

  • Analysis of risk factors associated with cerebrovascular and cardiovascular diseases.
  • Evaluation of the efficacy of aspirin and other antiplatelet agents.

    • Main Results:

    • Aspirin is identified as a promising long-term antithrombotic treatment, though optimal dosage requires further investigation.
    • Ongoing trials are evaluating aspirin, other antiplatelet agents, carotid endarterectomy, and bypass surgery.
    • The pathophysiology and treatment of TIAs may share similarities with focal cerebral ischemia that resolves over days or weeks.

    Conclusions:

    • Accurate diagnosis and comprehensive management of vascular risk factors are paramount in TIA care.
    • Further research and clinical trials are essential to optimize TIA treatment strategies.
    • The long-term prognosis and management of TIAs warrant continued investigation and clinical support.